|
[1]
|
Tsao, C.W., Aday, A.W., Almarzooq, Z.I., et al. (2023) Heart Disease and Stroke Statistics—2023 Update: A Report from the American Heart Association. Circulation, 147, e93-e621. [Google Scholar] [CrossRef]
|
|
[2]
|
Imanaka-Yoshida, K., Tawara, I. and Yoshida, T. (2020) Tenascin-C in Cardiac Disease: A Sophisticated Controller of Inflammation, Repair, and Fibrosis. American Journal of Physiology-Cell Physiology, 319, C781-C796. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Iyoda, T., Ohishi, A., Wang, Y., Yokoyama, M., Kazama, M., Okita, N., et al. (2024) Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation. International Journal of Molecular Sciences, 25, Article 1825. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Podesser, B.K., Kreibich, M., Dzilic, E., Santer, D., Förster, L., Trojanek, S., et al. (2018) Tenascin-C Promotes Chronic Pressure Overload-Induced Cardiac Dysfunction, Hypertrophy and Myocardial Fibrosis. Journal of Hypertension, 36, 847-856. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Gholipour, A., Shakerian, F., Zahedmehr, A., Oveisee, M., Maleki, M., Mowla, S.J., et al. (2022) Tenascin-C as a Noninvasive Biomarker of Coronary Artery Disease. Molecular Biology Reports, 49, 9267-9273. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Silvestre-Roig, C., Braster, Q., Ortega-Gomez, A. and Soehnlein, O. (2020) Neutrophils as Regulators of Cardiovascular Inflammation. Nature Reviews Cardiology, 17, 327-340. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Schoch, L., Alcover, S., Padró, T., Ben-Aicha, S., Mendieta, G., Badimon, L., et al. (2023) Update of HDL in Atherosclerotic Cardiovascular Disease. Clínica e Investigación en Arteriosclerosis, 35, 297-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694.
|
|
[10]
|
中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中华急诊医学杂志, 2019, 28(4): 421-428.
|
|
[11]
|
Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A guide for Gensini Score calculation. Atherosclerosis, 287, 181-183. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Marzeda, A.M. and Midwood, K.S. (2018) Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity. Journal of Histochemistry & Cytochemistry, 66, 289-304. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Shi, X., Zhu, S., Liu, M., Stone, S.S., Rong, Y., Mao, K., et al. (2022) Single-Cell RNA-Seq Reveals a Population of Smooth Muscle Cells Responsible for Atherogenesis. Aging and disease, 13, 1939-1953. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Schaff, M., Receveur, N., Bourdon, C., Wurtz, V., Denis, C.V., Orend, G., et al. (2011) Novel Function of Tenascin-C, a Matrix Protein Relevant to Atherosclerosis, in Platelet Recruitment and Activation under Flow. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 117-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kimura, T., Tajiri, K., Sato, A., Sakai, S., Wang, Z., Yoshida, T., et al. (2018) Tenascin-c Accelerates Adverse Ventricular Remodelling after Myocardial Infarction by Modulating Macrophage Polarization. Cardiovascular Research, 115, 614-624. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Li, Y., Liu, J., Huang, J., Song, J., Ma, Z. and Shi, H. (2018) In Vivo MRI Detection of Atherosclerosis in Apoe-Deficient Mice by Using Tenascin-C-Targeted Uspio. Acta Radiologica, 59, 1431-1437. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Gao, W., Li, J., Ni, H., Shi, H., Qi, Z., Zhu, S., et al. (2019) Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 26, 31-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Xu, S., Zhang, T., Cao, Z., Zhong, W., Zhang, C., Li, H., et al. (2021) Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights. Frontiers in Immunology, 12, Article 638400. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sasmita, B.R., Zhu, Y., Gan, H., Hu, X., Xue, Y., Xiang, Z., et al. (2021) Leukocyte and Its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study. Shock, 57, 351-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Güven, R., Akyol, K.C., Bayar, N., et al. (2018) Neutrophil Count as a Predictor of Critical Coronary Artery Stenosis in Young Patients. Iranian Journal of Public Health, 47, 765-767.
|
|
[21]
|
Ozgeyik, M. and Ozgeyik, M.O. (2021) Long-Term Prognosis after Treatment of Total Occluded Coronary Artery Is Well Predicted by Neutrophil to High-Density Lipoprotein Ratio: A Comparison Study. Kardiologiia, 61, 60-67. [Google Scholar] [CrossRef] [PubMed]
|